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Introduction
MicroRNA (miRNA) regulation of protein expression adds a 
subtle layer of complex fine-tuning on top of numerous modes 
of protein production and destruction. miRNAs typically bind 
to specific sites within the 3′ untranslated regions (3′-UTRs) of 
their target mRNAs, to impart post-transcriptional silencing, 
either through translational repression and/or mRNA decay.1,2 
In animals, miRNAs typically exhibit partial complementary 
base pairing to their mRNA targets, with the “seed region” 
of six to eight nucleotides toward the 5′end of the miRNA 
being important for target specificity.3 miRNA target efficacy 
is predicted to increase with the number of Watson-Crick 
matches to the seed region and is also dependent on base 
composition at nucleotide position 1.2,4 For example, a perfect 
match to nucleotides 2-8, referred to as a “7Mer-m8” target 
site, has a higher hierarchy rating compared to a “7Mer-A1” 
target site, which only confers Watson-Crick base pairing to 
nucleotides 2-7.3 Noticeably, the latter has an A at nucleotide 
position 1, which again rates it higher than a “6Mer” with 
the same 2-7 seed match, but a different number 1 nucleotide 
(C, G, or T).4 However, other factors such as AU-rich neighbor 
nucleotides and accessibility may also influence site-efficacy.5,6 
Hence, miRNAs target specific genes for post-transcriptional 
regulation, fine-tuning protein expression levels during criti-
cal processes such as cell proliferation, differentiation, and 
maturation.7
The functional roles of microRNA-7 (miR-7) have been 
extensively studied, as it is highly conserved, being detected 
in 81 species (October 2013: http://www.mirbase.org),8–10 
and controls multiple cell signaling networks, including 
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epidermal growth factor receptor,11 insulin-like growth 
factor,12 Hedgehog,13 and the mammalian target of rapamy-
cin (mTOR) signaling pathways.14 miR-7 is also a critical 
regulator of multiple regulatory genes, including paired box 
gene 6 (PAX6) in mice.8,9 PAX6 encodes a neurogenic tran-
scription factor, which is highly conserved, both structurally 
and functionally, and is critical for neural tube polarization, 
brain regionalization, and eye formation.15–17 PAX6 is widely 
co-expressed with miR-7 in several tissues including the fore-
brain, pancreas, and retina where it is involved in regulating 
cellular differentiation.8–10
Given the functional importance of the miR-7/PAX6 
regulatory apparatus in controlling cell fate in mouse, we 
sought to evaluate whether this mechanism was conserved in 
humans. Herein we use bioinformatics to predict three miR-7 
target sites in the human PAX6 3′-UTR and reporter gene 
assays to confirm the functional capacity of two of these pre-
dicted target sites. Further, we compare the human PAX6 
3′-UTR region across species and identify a conserved miR-7 
3′-UTR target site present in many species, as well as a second 
functional miR-7 target site in the human PAX6 3′-UTR that 
is specific to primates.
Materials and Methods
Prediction of mir-7 target sites. 3′-UTRs were identi-
fied using the “Spidey” freeware, which is part of the NCBI 
toolkit (http://www.ncbi.nlm.nih.gov/spidey/). Target sites 
for hsa-miR-7 within human PAX6 3′-UTR (GenBank 
accession number: NM_001127612) were predicted using 
TargetScan software (release 6.2)4 with the following search 
criteria: species: human, human Entrez gene symbol: PAX6, 
and miRNA name: hsa-miR-7. Target sites for miR-7 in 
3′-UTRs of other species (GenBank accession numbers given 
in Supplementary Table 1) were predicted using a “Find in 
This Sequence” function available at GenBank to search for 
the miR-7 seed region (5′-GUCUUCC-3′). Notably, only 
species that encode miR-7 (mirbase.org) are included in the 
analysis. Nucleotide position numbers for 3′-UTRs are listed 
in Supplementary Table 1.
Luciferase reporter constructs. Luciferase reporter plasmids 
were generated by ligating annealed DNA oligo nucleotides 
containing each of the three predicted PAX6 3′-UTR hsa-miR-7 
7mer targets sites (NM_001127612.1; m8#1: nt. 2389–2441, 
m8#2: nt. 3613–3664, and A1#3: nt. 4170–4216) to the pMiR-
REPORT luciferase plasmid (Ambion) via HindIII and SpeI 
restriction sites. Mutated (Mut) miR-7 seed target sites with 
three nucleotide substitutions were generated following the 
same procedure (for sequences refer to Supplementary Table 2). 
A perfect hsa-miR-7 target site (forward: 5′-CAACAAAAT-
CACTAGTCTTCCA-3′ and reverse: 5′-TGGAAGAC-
TAGTGATTTTGTTG-3′) inserted in the pGL3-control 
(Promega) firefly luciferase reporter vector was used as a control 
as previously described.11,18 Sequences of all plasmids were con-
firmed by Sanger DNA sequencing.
cell culture. HeLa and HEK293 cells were obtained from 
the American Type Culture Collection (ATCC) and main-
tained at 37 °C and 5% CO2 in Dulbecco’s modified Eagle’s 
medium (DMEM)/F-12-GlutaMAX (Life Technologies) 
supplemented with 5% fetal bovine serum (Serana) and 100 
units/mL of Penicillin/Streptomycin (Life Technologies).
Luciferase assays. HEK293 cells in 24-well plates 
were co-transfected with 1) firefly luciferase reporter plasmid 
DNA (100 ng) containing either PAX6 3′-UTR WT or Mut 
miR-7 target sites (7mer-m8#1, 7mer-m8#2, and 7mer-A1#3), 
2) a control pRL-CMV Renilla luciferase reporter plasmid 
(5 ng), and 3) precursor miRNAs (30 nM) purchased from 
Ambion, corresponding to human miR-7 (ID: PM10047) 
or a miRNA negative control (miR-NC) (ID: AM17110) 
using Lipofectamine 2000 (Invitrogen). Cells were har-
vested 24 hours post-transfection and assayed using a Dual-
Luciferase Reporter Assay System (Promega) and an EnSpire 
Multimode Plate Reader (PerkinElmer). For data analysis, 
firefly luciferase activity was firstly normalized to Renilla 
(transfection control) and then hsa-miR-7 was normalized to 
miR-NC transfected cells.
transfection. HeLa cells were seeded 24 hours before 
transfection with miR-7 or miR-NC miRNA precursor 
molecules (30 nM) using RNAi/MAX transfection reagent 
(Invitrogen). Cells were harvested at 24 hours (for RNA) or 
72 hours (for protein) post-transfection.
western blotting. HeLa cells were lysed by sonication 
(4 × 5 seconds) in ice-cold lysis buffer (0.1% SDS, 10 mM 
Tris–HCl pH 7.5) containing 1× complete inhibitor cock-
tail tablet (Roche) and protein concentrations determined by 
Bradford assay (Bio-Rad). Samples (70 µg) were electropho-
retically separated on a 12.5% polyacrylamide gel, transferred 
to a Hybond-P membrane (Amersham Biosciences), and 
probed with anti-PAX6 (1:1,000; Abcam Clone AD2.38) or 
anti-β-actin (1:10,000; Sigma-Aldrich Clone AC-15) mouse 
monoclonal antibodies before detection with the commer-
cially available Qdot 625 system (Molecular Probes) and UV 
light using Universal Hood II (Bio-Rad) for visualization of a 
representative image. A colored ladder was used to determine 
protein size (Marker Precision Plus Protein Kaleidoscope 
standard; Bio-Rad).
rt-qPcr. Total RNA was extracted (SV Total RNA 
Isolation System; Promega), quality assessed, and quanti-
fied using a NanoDrop 1000 Spectrophotometer (Thermo 
Scientific) with threshold cutoff for DNA contamination 
(260/280) at 2.0. cDNA was synthesized (SuperScript III; 
Invitrogen) using 250 ng RNA and random hexam-
ers according to the manufacturer’s instructions. qPCR 
assays were performed using a Rotor-Gene Q (Qiagen) 
with SYBR-Green chemistry (GoTaq qPCR Master Mix; 
Promega) and previously published gene-specific primers: 
PAX619–21 forward: 5′-TCTTTGCTTGGGAAATCCG-3′ 
and reverse: 5′-CTGCCCGTTCAACATCCTTAG-3′; 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)22–25 
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forward: 5′-GAAGGTGAAGGTCGGAGTC-3′ and 
reverse: 5′-GAAGATGGTGATGGGATTTC-3′. Primer-
specificity was tested using gel electrophoresis (to verify single 
band and amplicon size), DNA sequencing, and melting pro-
file. A no-reverse transcription control was included in each 
run for detection of potential PCR contamination. Normalized 
PAX6 expression relative to GAPDH was calculated using the 
2−∆∆Ct  method.26
statistical analysis. Data are presented as mean of three 
independent experiments (n = 3) + standard deviation (SD). 
Significance (P , 0.05) was assessed using a paired t-test (RT-
qPCR) and ANOVA Tukey’s post-hoc analysis (luciferase 
assay) in R (version 3.0.2).27
results and discussion
The human PAX6 3′-Utr contains two functional 
mir-7 target sites. There are seven verified human PAX6 tran-
scripts in the NCBI database, which result from alternative 
splicing and alternative initiation of transcription. However, it 
is noteworthy that they all share identical 3′-UTRs accounting 
for approximately 75% of the total mRNA sequence, which 
allows for the suggestion that PAX6 expression is possibly reg-
ulated by miRNAs. Using TargetScan software,4 we identified 
three miR-7 target sites: one of which (m8#1) has previously 
been shown to regulate PAX6 expression in mouse9 and two 
additional miR-7 target sites (m8#2 and A1#3) were predicted 
when poorly conserved target sites were considered (Fig. 1A). 
Two of the three predicted miR-7 target sites within the PAX6 
3′-UTR contained 7mer-m8 seed matches (m8#1 and m8#2), 
whereas the third target site contained a lower hierarchy 
7mer-A1 seed match (A1#3)4 (Fig. 1B). Noticeably, the A1#3 
target site has a mismatch at position 8 in the miR-7 sequence 
(Fig. 1B), which has been shown to be essential for functional 
miR-7-target binding.28
To examine the functional significance of the three pre-
dicted human miR-7 target sites within the PAX6 3′-UTR, 
we generated firefly luciferase reporter constructs containing 
each of these individual sites, as well as Mut constructs of 
each. We then co-transfected HEK293 cells with the firefly 
and Renilla (transfection control) luciferase constructs and 
either hsa-miR-7 or miR-NC (a negative control) precursor 
miRNAs to assess target specificity. To confirm the reliability 
of our assay, we first measured luciferase activity of a construct 
containing a perfect miR-7 target site (5′-CAACAAAAT-
CACTAGTCTTCCA-3′), which resulted in a 99% reduc-
tion in luciferase activity (Renilla normalized) compared to 
cells transfected with miR-NC precursors (Fig. 1C). Assess-
ment of cells transfected with PAX6 3′-UTR target site fire-
fly luciferase reporter plasmids revealed that two of the three 
miR-7 target sites (m8#1 and m8#2) were functionally active, 
each yielding a significant reduction in luciferase activity of 
approximately 45% with miR-7 relative to their Mut target 
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figure 1. the human PAX6 3′-UTR contains two specific, functional miR-7 target sites. (A) Prediction of mirna-7 target sites within the human PAX6 
3′-UTR. Black line (top) illustrates the length of the PAX6 3′-UTR (k = kilobase), and asterisks illustrate predicted mir-7 target sites (m8#1, m8#2, and 
a1#3). (b) alignment of predicted human PAX6 mir-7 target sites (top) to mir-7 (bottom). the seed target region (Gucuucc) is in bold, and the seed 
matches, target sites, and positions are given. (C) Luciferase assays using firefly reporter constructs with predicted (WT: wild type and Mut) miR-7 7mer 
target sites (m8#1, m8#2, and A1#3) and a perfect miR-7 target site (PT) as a positive control. The firefly luciferase reporters were co-transfected into 
HEK293 cells with a Renilla luciferase reporter as a transfection control and either miR-7 or miR-NC precursors. Relative luciferase expression (firefly 
normalized to Renilla) values of hsa-mir-7 were normalized to mir-nc transfected controls, and is given as mean + sD. the relative luciferase activity 
(firefly normalized to Renilla) of the positive control was calculated as mir-7 relative to mir-nc and is given as mean + sD, *P , 0.05.
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site reporters (Fig. 1C). Both of these active sites contained 
7mer-m8-predicted miR-7 target sites, whereas the third site 
(7mer-A1#3) did not show any regulation by miR-7. Our study 
therefore confirms previous findings, showing that Watson-
Crick base pairing to nucleotide position 8 is essential for 
functional miR-7-target binding.28
Taken together, these data indicate that the PAX6 3′-UTR 
contains two 7 mer-m8 miR-7 seed sites. A third predicted 
7 mer-A1 miR-7 target site that did not comply with Watson-
Crick pairing at nucleotide 8 failed to show functional activity 
in luciferase reporter assays.
PAX6 protein expression is regulated by mir-7 in 
human cells. To assess whether miR-7 regulates PAX6 protein 
expression in human cells, we transiently transfected HeLa, 
a human cervical cancer cell line, with miR-7 precursor mol-
ecules and measured PAX6 levels by Western blotting. Com-
pared with a negative miRNA precursor molecule (miR-NC), 
miR-7 reduced expression of PAX6 in HeLa cells (Fig. 2A). 
To determine whether miR-7 reduced PAX6 protein levels 
through interfering with the translational pathway or mediat-
ing mRNA decay, we assessed endogenous PAX6 mRNA lev-
els by RT-qPCR; however, we saw no significant difference in 
PAX6 mRNA expression between HeLa cells transfected with 
hsa-miR-7 or miR-NC miRNA precursor molecules (Fig. 2B).
Taken together, these data indicate that miR-7 regulates 
PAX6 protein levels in human cells, but has no significant 
effect on mRNA levels, which suggests that miR-7 interferes 
with the translational pathway rather than mediating PAX6 
mRNA decay.
diversification of PAX6 3′-Utr mir-7 target sites 
across species. Recent experiments in mice have demonstrated 
that miR-7 directly represses the expression of PAX6 through 
a single miR-7 target site in the mouse PAX6 3′-UTR.8,9 
Given our identification of a second functional miR-7 target 
site (7mer-m8) in human PAX6 3′-UTR compared to mouse, 
we examined the evolutionary conservation of PAX6 3′-UTRs 
and their miR-7 target sites across species, and found that the 
length of PAX6 3′-UTRs varied considerably and that this 
length seemed to be associated with the number of predicted 
miR-7 target sites (Fig. 3A). For example, in primates, human 
(Homo sapiens) and rhesus monkey (Macaca mulatta), PAX6 has 
relatively long 3′-UTRs (accounting for more than 70% of the 
total mRNA sequences), and we demonstrated the existence 
of two functional 7mer-m8 miR-7 target sites within these 
regions. In comparison, the 3′-UTRs of pig (Sus scrofa), rodents 
(Mus musculus and Rattus norvegicus), frog (Xenopus tropicalis) 
and fish (Danio rerio) account for between 30 and 39% of total 
PAX6 mRNA length and contain only one predicted miR-7 
target site (Fig. 3A). In other species such as chicken (Gallus 
gallus) and fruit fly (Drosophila melanogaster), where the 3′-UTR 
accounts for less than 20% of the total PAX6 mRNA sequence, 
no miR-7 target sites were predicted (Fig. 3A). Notably, in 
zebrafish, there are two duplicated PAX6 gene variants, PAX6a 
and PAX6b, with distinct 3′-UTR lengths, accounting for 
34%–39% of the total mRNA lengths, respectively (Fig. 3A). 
PAX6a contains a single predicted miR-7 target site, whereas 
no site was predicted in the shorter 3′-UTR of the PAX6b vari-
ant, suggesting that perhaps only PAX6a is post-transcription-
ally regulated by miR-7. Also, the fruit fly has multiple PAX6 
gene loci, from which six different PAX6 3′-UTRs are tran-
scribed; none have a predicted miR-7 target site in the 3′-UTR 
despite one transcript having a 3′-UTR that accounts for more 
than 45% of the total mRNA sequence (Fig. 3A), suggesting 
that miR-7 might not regulate PAX6 expression levels in fruit 
flies. These results are in agreement with previous work that 
suggested the expansion of 3′-UTR sequences increases with 
organism complexity throughout evolution.29
In species with a predicted miR-7 target site in the PAX6 
3′-UTR, sequence alignment revealed that 20 of 23 nucle-
otides were conserved and that all predicted miR-7 target 
sites shared identical 7mer-m8 seed regions (Fig. 3B). Thus, 
the first functional human 7mer-m8 PAX6 miR-7 target site 
(more 5′-located; m8#1 in Figure 1) appears to be conserved, 
whereas the second functional human 7mer-m8 miR-7 target 
site (more 3′-located; m8#2 in Figure 1) does not. The iden-
tification of a miR-7 target site positioned outside the con-
served region suggests that this site may have resulted from 
the expansion of the PAX6 3′-UTR. The appearance of mul-
tiple functional miR-7 binding sites within the human PAX6 
3′-UTR suggests an added level of complexity by allowing 
the combinatorial regulation of PAX6 expression by miR-7.7
In summary, given our finding that miR-7 can regulate 
PAX6 expression via two miR-7 target sites in a human cell 
line, future experiments are needed to examine the physi-
ological importance of this regulatory system, in particular, 
examining whether there is a combinatory effect between the 
two functional human miR-7 target sites (m8#1 and m8#2) 
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figure 2. mir-7 reduces PaX6 protein expression in human cells 
without inducing PaX6 mrna decay. (A) Western blot analysis of 
Hela cells transfected with hsa-mir-7 (lane 1) or control non-coding 
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or if a dysfunctional miR-7/PAX6 regulatory system pro-
motes tumorigenesis, as both factors are highly associated 
with cancer.30–34
conclusions
In conclusion, we provide the first demonstration that miR-7 
regulates the expression of PAX6 protein in human cells, 
and show that this regulation occurs via two target sites 
within the PAX6 3′-UTR: the first site is highly conserved 
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figure 3. Diversification of the PAX6 3′-UTR and prediction of 7mer-m8 target sites. (A) schematic representation of validated PAX6 mrnas from the 
following species: H. sapiens (human), M. mulatta (rhesus monkey), S. scrofa (pig), M. musculus (mouse), R. norvegicus (rat), G. gallus (chicken),  
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across species, whereas the second functional miR-7 site is 
conserved only in primates. This finding leads to the intrigu-
ing possibility that the expanded 3′-UTR found in human 
PAX6 may allow for a tighter control of PAX6 expression by 
miR-7 than that already documented in mouse.
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table 2. Oligonucleotides used for generating firefly luciferase constructs.
tARgEt SitES oligonuClEotidES (5′→3′)
m8#1 Wt sE AGCTttctGaGGatttctAgggAAgACAAAtACttACAttttGacataaaacaaatt
as CTAGaatttGttttatGtcAAAAtgtAAgtAtttgtCttCCCtaGaaatcctcaGaa
mut sE AGCTttctGaGGatttctAggaAGgGCAAAtACttACAttttGacataaaacaaatt
as CTAGaatttGttttatGtcAAAAtgtAAgtAtttgcCcttCCtaGaaatcctcaGaa
m8#2 Wt sE AGCTaGtGaaGtttGcaGAggAAgACttAtCtgtAttgACttatatGttGcacaGa
as CTAGtctGtGcaacatataAgtCAAtACAgAtAAgtCttCCtctGcaaacttcact
mut sE AGCTaGtGaaGtttGcaGAgaAGgGCttAtCtgtAttgACttatatGttGcacaGa
as CTAGtctGtGcaacatataAgtCAAtACAgAtAAgcCcttCtctGcaaacttcact
a1#3 Wt sE AGCTcaaataatctccatcctggAAgAtggtgtCAAAACAtCcctGcaGatacccca
as CTAGtGGGGtatctGcaGGgAtgttttgACACCAtCttCCAGGatGGaGattatttG
mut sE AGCTcaaataatctccatcctgaAGgGtggtgtCAAAACAtccctGcaGatacccca
as CTAGtGGGGtatctGcaGGgAtgttttgACACCAcCcttCAGGatGGaGattatttG
notes: List of sense (SE) and antisense (AS) oligonucleotides used for generating firefly luciferase constructs containing WT and Mut miR-7 7mer target sites 
(m8#1, m8#2, and a1#3). italic, bold, and underlined nucleotides represent restriction recognition-, mir-7 target- and mut sites, respectively.
table 1. PAX6 3′untranslated regions.
SPECiES vARiAntS ACCESSion numbERS 3´utR (StARt-StoP)
Homo Sapiens n/a nm_001127612.1 1739–6883
Macaca mulatta n/a nm_001266257.1 1711–5908
Sus scrofa n/a nm_001244172.1 1728–2643
Mus musculus n/a nm_001244198.1 1597–2619
Rattus norvegicus n/a nm_013001.2 1430–2191
Gallus gallus n/a nm_205066.1 1641–1961
Xenopus tropicalis n/a nm_001006762.1 1651–2361
Danio rerio PAX6a nm_131304.1 1845–2809
PAX6b nm_131641.1 1575–1733
Drosophila Melanogaster Eyeless (Ey) nm_166789.2 2621–2851
Twin of eyeless
(Toy)
variant a nm_079899.4 2160–2287
variant c nm_00127215.1 2109–3870
Eyegone (Eyg) nm_001014582.1 2350–2586
Twin of eyegone
(Toe)
variant a nm_079317.3 2279–2400
variant b nm_001274833.1 2030–2303
notes: list of PAX6 GenBank accession numbers, n/a = “not applicable.” Nucleotide position numbers for the 5′end (start) and 3′end (stop) of the 3′-UTRs are listed.
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